There is currently significant respiratory virus activity in the EU/EEA, with both influenza and RSV epidemics ongoing. Vaccination campaigns against respiratory pathogens continue in many EU/EEA countries, and people eligible for vaccination are encouraged to get vaccinated.
ECDC and DG SANTE jointly carried out this country visit to Sweden from 16 to 20 September 2024 to assist in the review of their national strategy and plan for tackling antimicrobial resistance (AMR), based on a One Health approach.
An e-learning course to introduce the concept of vaccine acceptance, the main themes of behaviour change related to vaccine acceptance and to present communication as a supportive tool to help persons to take important decisions for their health.
Bringing together over 100 global public health leaders, policymakers, and stakeholders, the "Progress Towards Hepatitis C Elimination" conference in Cairo marked a major milestone in the fight against this disease.
The second EU Health Task Force (EUHTF) stakeholder meeting gathered representatives from EU/EEA Member States, EU agencies, the European Commission, and partner organisations including the World Health Organization (WHO), Global Outbreak Alert and Response Network (GOARN), Doctors Without Borders (MSF) and the International Federation of the Red Cross (IFRC) on 18-19 November 2024.
During their two-year fellowship, ECDC Fellowship Programme fellows are placed in different training sites.
Training sites selected to host a fellow are those with responsibilities for communicable disease surveillance, epidemiology, and public health advice. Selection criteria include an assessment of the training site’s potential for the practice of intervention epidemiology or public health microbiology and the quality of training supervision available for the fellows.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya in its weekly threat report (Communicable Diseases Threat Report).
Increasing incidence of bloodstream infections with Enterobacterales resistant to carbapenem antibiotics poses a significant threat to patients and healthcare systems in the EU/EEA.
Carbapenem resistance in Enterobacterales, such as Klebsiella pneumoniae and Escherichia coli, poses a significant threat to patients and healthcare systems in European Union/European Economic Area (EU/EEA) countries.
This initiative aims to enhance regional cooperation to tackle cross-border health security threats in EU candidate and potential candidates countries and European Neighbourhood Policy partner countries.